G
Terri Getzug, MD
Dr. Getzug is the director of the Familial Mediterranean Fever (FMF) Clinic which is the only clinic of its kind in the United States and a major referral center for this under-recognized and very treatable condition. More than 700 patients have been registered at the FMF clinic since its inception in the early 1960’s.
Dr. Getzug graduated from the University of California at Davis with a major in Nutritional Sciences. She received her medical degree from the Keck School of Medicine at USC and completed her internship, residency and gastroenterology fellowship training at UCLA. She is a member of the Alpha Omega Alpha Honor Medical Society.
Dr. Getzug has been on the UCLA faculty since 1991. Her primary areas of interest are general gastroenterology, functional bowel disease, celiac disease, inflammatory bowel diseases, motility, colon cancer screening and acid peptic disorders. She has extensive expertise treating patients with the gastrointestinal complications of scleroderma.
UCLA Digestive Disease Center 100 UCLA Medical Plaza Los Angeles CA 90095
Michael Goldstein, PhD
Michael S. Goldstein, PhD, is a professor of public health (community health sciences) and sociology, and UCLA’s associate vice-provost in charge of the Healthy Campus Initiative. He has also served the campus as interim vice provost for graduate education and dean of the graduate division.A faculty associate at the Center, Goldstein was co-principal investigator and program director of CHIS-CAM, an NCI-funded follow-up study to the 2001 California Health Interview Survey that examines use of complementary and alternative medicine (CAM) among California adults, particularly those with cancer and other chronic illnesses. At UCLA, he teaches graduate courses on complementary and alternative medicine, self-help and self-care.Goldstein’s published research on CAM spans 30 years.During the late 1980s his research examined factors that led conventionally trained physicians to become involved with CAM. In the early 1990s, Goldstein spent two years conducting research at The Wellness Community, a support center for people with cancer that is receptive to many forms of CAM. In the mid-1990s, he was among the very first researchers supported by the Office of Alternative Medicine for his study of patient satisfaction with homeopathic treatment. More recently, he collaborated on a study to compare the impact of treatment confidence on pain and disability among patients with low-back pain treated by either physicians or chiropractors. His current work deals with the potential for CAM providers to assume a greater role in the provision of primary care in the nation’s health care system.
Goldstein is the author of two books: The Health Movement: Promoting Fitness in America (Macmillan 1992), and Alternative Health Care: Medicine, Miracle, or Mirage(Temple Univ. 1999). Both strive to understand changes in the way people seek to prevent and respond to serious illnesses, like cancer, as part of broader social and cultural changes in American society.
Goldstein received his doctorate from Brown University and has conducted research on a wide array of topics dealing with the behavior of people with chronic illness.
CHS 21-261 UCLA School of Public Helath Los Angeles CA 90095
Arpana Gupta, PhD
Arpana Gupta is an Assistant Professor and Director of the Neuroimaging Core at the UCLA G. Oppenheimer Center of Neurobiology of Stress and Resilience (CNSR); where she specializes in research that investigates the interactions between environmental and biological factors in shaping neurobiological phenotypes associated with stress-based diseases such as obesity and metabolic syndrome. Her current program of research, broadly defined, is based on developing a model that aims to understand the bidirectional interaction of the brain with those in the periphery (immune cells, gut microbiota-related metabolites), and the modification of these interactions by vulnerability or protective factors (adverse life events, sex, race, socioeconomic status [SES], resilience, diet) related to obesity and ingestive behaviors. More recently she has been investigating diet interventions in altering the brain-gut microbiome axis on health and disease. Another main area of interest is sex differences in central responses related to the brain-gut microbiome axis, as well as its relationship to various disease states. She applies advanced multivariate analytic techniques in order to integrate data from multiple neuroimaging sources, inflammatory markers, microbiome and metabolite profiles, and behavioral data, in order to determine the unique variance associated with altered brain gut microbiome axis in specific disorders. In 2016, she received a mentored K23 grant and in 2020 a R03 grant from the NIH NIDDK to investigate the brain-gut microbiome influences in obesity. She has also received funding from the AGA Rome Foundation, Biocodex, and pilot funds from the UCLA CURE/CTSI program.
Publications
http://www.ncbi.nlm.nih.gov/sites/myncbi/1v_1kl872tPQf/bibliography/46222127/public
10833 Le Conte Avenue Center for Health Sciences 42-210 Los Angeles CA 90095 United States